Naratriptan is Effective and Well Tolerated in the Acute Treatment of Migraine
Neurol 49:1485-1490, Mathew,T.,et al, 1997
If First AED Fails to Control Child's Epilepsy, What Are the Chances of Success with Next Drug
J Pediatr 131:821-824, 7941997., Camfield,P.R.,et al, 1997
A Meta-Analytic Review of the Preventive Treatment of Recurrences of Febrile Seizures
J Pediatr 131:922-925, Rantala,H.,et al, 1997
Treatment of First Tonic-Clonic Seizure Does Not Improve the Prognosis of Epilepsy
Neurol 49:991-998, Musicco,M.,et al, 1997
A Pharmacoeconomic Eval of IV Fosphenytoin (Cerebyx) vs IV Phenytoin (Dilantin) in Hosp ER Dept
Clin Therapeutics 18:953-966, Marchetti,A.,et al, 1996
Rizatriptan vs Sumatriptan in Acute Trmt of Migraine. Dutch/US Rizatriptan Study Group
Arch Neurol 53:1132-1137, Visser,W.H.,et al, 1996
Topiramate Placebo-Controlled Dose-Ranging Trial in Refractory partial Epilepsy Using 200-, 400-, and 600-mg Daily Dosages
Neurol 46:1684-1690, Faught,E.,et al, 1996
The "Target Sign": Is it a Specific Sign of CNS Tuberculoma?
Neuroradiology 38:547-550, Bargallo,J.,et al, 1996
Low-Dose Oral Methotrexate in Chronic Progressive Multiple Sclerosis:Analyses of Serial MRIs
Neurol 47:1153-1157, Goodkin,D.E.,et al, 1996
Linomide Reduces the Rate of Active Lesions in Relapsing-Remitting Multiple Sclerosis
Neurol 47:895-900, Anderson,O.,et al, 1996
Treatment of End Stage Dilated Cardiomyopathy
Br Heart J 72:S52-S56, O'Connell,J.B.,et al, 1996
Exquisite Sensitivity of Paroxysmal Kinesigenic Choreoathetosis to Carbamazepine
Neurol 47:1104-1106, Wein,T.,et al, 1996
Treatment with Oral 3, 4 Diaminopyridine Improves Leg Strength in Multiple Sclerosis Patients
Neurol 47:1457-1462, Bever,C.T.,et al, 1996
Relevence of Early Seizures for In-Hospital Mortality in Acute Cerebrovascular Disease
Neurol 47:1429-1435, Arboix,A.,et al, 1996
Epidemiology of Stroke
JNNP 61:333-338, Khaw,K.T., 1996
Status of Antithrombotic Therapy for Patients with Atrial Firbrillation in University Hospitals
Arch Int Med 156:2311-2316, Albers,G.W.,et al, 1996
A Randomised
Blinded Trial of Clopidogrel vs. Aspirin in Patients at Risk of Ischaemic Events (CAPRIE) , CAPRIE S, eerimte,Lancet 348:1329-1339,1996., 1996
Childhood Leukemia:Central Nervous System Abnormalities During and After Treatment
AJNR 17:295-310, Chen,C-Y.,et al, 1996
New Antiepileptic Drugs
NEJM 334:1583-1590, Dichter,M.A.&Brodie,M.J., 1996
Discontinuation of Anticonvulsant Therapy in Children Free of Seizures for 1 Year:A Prospective Study
Neurol 46:969-974, Dooley,J.,et al, 1996
Practice Parameter:A Guideline for Discontinuing Antiepileptic Drugs in Seizure-Free Patients-Summary Statement
Neurol 47:600-602, Rosenberg,J.H., 1996
Temporal Lobectomy for Refractory Epilepsy
JAMA 276:470-475, Sperling,M.R.,et al, 1996
Practice Parameter:The Neurodiagnostic Evaluation of the Child with First Simple Febrile Seizure
Pediatrics 97:769-772, Bergman,D.A.,et al, 1996
Simple Partial Status Epilepticus:Causes, Treatment and Outcome in 47 Patients
JNNP 61:90-92, Scholtes,F.B.,et al, 1996
Non-Convulsive Status Epilepticus:Causes, Treatment, and Outcome in 65 Patients
JNNP 61:93-95, Scholtes,F.B.,et al, 1996
Random Comp Monother Trial of Phenobarb, Phenytoin, Carbamazepine, or Sod Valp for Newly Dx Child Epilep
Lancet 347:709-713, deSilva,M.,et al, 1996
Reversible Parkinsonism and Cognitive Impairment with Chronic Valproate Use
Neurol 47:626-635, Armon,C.,et al, 1996
Efficacy of Gabapentin Therapy in Children with Refractory Partial Seizures
J Pediatr 128:829-833, Khurana,D.S.,et al, 1996
Choreoathetotic Movements:A Possible Side Effect of Gabapentin
Neurol 46:851-852, Buetefisch,C.M.,et al, 1996
Exacerbation of Seizures in Lennox-Gestaut Syndrome by Gabapentin
Neurol 46:852-853, Vossler,D.G., 1996
A Randomized, Blinded, Placebo-Controlled Trial of Divalproex Sodium Prophylaxis in Adults with Newly Diagnosed Brain Tumors
Neurol 46:985-991, Glantz,M.J.,et al, 1996
The Use of Parenteral Antiepileptic Drugs & The Role of Fosphenytoin
(Suppl Editor) , Neurol 46:S1-S2896., Wilder,B.J., 1996
Safety & Toler of Multi Doses of Intramusc Fosphenytoin Substi for Oral Phenytoin in Epilep or Neurosurg
Arch Neurol 53:764-768, Wilder,B.J.,et al, 1996
Adjusted-Dose Warfarin Vs Low-Intens
Fixed-Dose Warfarin+Aspirin for High-Risk Pts with Atrial Fib, SPAFIII Invest, Lancet 348:633-638996, , 1996
Prognosis After Stroke Followed by Surgical Closure of Patent Foramen Ovale
Neurol 47:1162-1166, Devuyst,G.,et al, 1996
Pravastatin Reduces Carotid Intima-Media Thickness Prog in an Asympt Hypercholesterolemic Pop, CAIUS Study
Am J Med 101:627-634, Mercuri,M.,et al, 1996
Nerve Growth Factor and Diabetic Neuropathy
Lancet 348:1044-1045, Dyck,P.J., 1996
Routine Indomethacin Prophylaxis:Has the Time Come
Pediatrics 98:784-785, Bada,H.S., 1996
Prenatal Magnesium Sulfate Expos/Risk for CP or MR Among Very Low-Birth-Weight Child Aged 3-5 Yrs
JAMA 276:1805-1810, 18431996., Schendel,D.E.,et al, 1996
Stimulus-Evoked Sinus Arrest in Severe Guillain-Barre Syndrome:A Case Report
Neurol 47:1239-1242, Minahan,R.E.,et al, 1996
Acute Treatment of Migraine with Dihydroergotamine Nasal Spray
Arch Neurol 53:1285-1291, Gallagher,R.M., 1996
Estrogen Replacement Therapy and Risk of Alzheimer Disease
Arch Int Med 156:2213-2217, Paganinni-Hill,A.&Henderson,V.W., 1996
Neutralizing Antibodies During Treatment of Multiple Sclerosis with Interferon Beta-1b
IFNB MS Study Group & UBC MS. MRI Analysis Group, Neurol 47:889-8946., , 1996
Guidelines for Physicians with Patients on IFNB-1b:The Use of an Assay for Neutralizing Antibodies (NAB)
Neurol 47:865-866, Paty,D.,et al, 1996
Interferon Beta in Multiple Sclerosis
BMJ 313:1159, 1157, 1195996., Richards,R.G., 1996
Vagus Nerve Stimulation for the Treatment of Medically Intractable Seizures
Arch Neurol 53:1176-1180, Salinsky,M.C.,et al, 1996
Management Protocol for an Enhancing Cerebral Lesion in HIV Infection
Conn Medicine 60:649-651, Finelli,P.F., 1996
Selegiline and Mortality in Parkinson's Disease
Ann Neurol 40:841-845, Olanow,C.W.,et al, 1996
Acute Low Back Pain:A New Paradigm for Management
BMJ 313:1343-1344, Deyo,R.A., 1996
New Antiepileptic Drugs:A Systematic Review of Their Efficacy and Tolerability
BMJ 313:1169-1174, 1157, 1158996., Marson,A.G.,et al, 1996